Interpace Diagnostics Group, Inc. (IDXG) financial statements (2021 and earlier)
Company profile
| Business Address |
MORRIS CORPORATE CENTER 1, PARSIPPANY, NJ 07054 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 6 | 15 | 1 | 8 | 23 | 46 | |||
| Cash and cash equivalents | 6 | 15 | 1 | 8 | 23 | 46 | |||
| Short-term investments | 0 | 0 | 0 | ||||||
| Receivables | 9 | 3 | 2 | (0) | (0) | ||||
| Prepaid expense | 0 | ||||||||
| Deferred costs | 0 | 2 | |||||||
| Disposal group, including discontinued operation | 5 | 1 | |||||||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 7 | ||
| Other current assets | 2 | 1 | 1 | 3 | 7 | ||||
| Other undisclosed current assets | 0 | 3 | 13 | 8 | |||||
| Total current assets: | 18 | 20 | 4 | 19 | 45 | 63 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 1 | 1 | 1 | 1 | 3 | 3 | |||
| Long-term investments and receivables | 3 | 2 | |||||||
| Long-term investments | 3 | 2 | |||||||
| Intangible assets, net (including goodwill) | 30 | 33 | 36 | 43 | 110 | 3 | |||
| Goodwill | 16 | 3 | |||||||
| Intangible assets, net (excluding goodwill) | 30 | 33 | 36 | 43 | 94 | ||||
| Disposal group, including discontinued operation, noncurrent assets | 0 | 0 | 1 | ✕ | |||||
| Other noncurrent assets | 0 | 0 | 0 | 3 | 5 | ||||
| Prepaid expense and other noncurrent assets | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 1 | ||
| Assets of disposal group, including discontinued operation | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 0 | ||
| Other undisclosed noncurrent assets | (0) | (51) | (2) | ||||||
| Total noncurrent assets: | 31 | 34 | 38 | 49 | 71 | 6 | |||
| TOTAL ASSETS: | 48 | 54 | 42 | 68 | 116 | 69 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 8 | 7 | 12 | 10 | 28 | 22 | |||
| Accounts payable | 1 | 0 | 2 | 2 | 4 | 2 | |||
| Accrued liabilities | 5 | 5 | 6 | 6 | 15 | 10 | |||
| Employee-related liabilities | 1 | 1 | 4 | 2 | 8 | 10 | |||
| Interest and dividends payable | 0 | ||||||||
| Settlement liabilities | 1 | ✕ | |||||||
| Debt | 1 | ||||||||
| Restructuring reserve | 1 | ✕ | |||||||
| Liability for uncertainty in income taxes | 1 | 1 | |||||||
| Disposal group, including discontinued operation | 1 | 1 | 4 | 12 | 3 | 0 | |||
| Self insurance reserve | 0 | 1 | |||||||
| Business combination, contingent consideration, liability | 1 | ✕ | |||||||
| Deferred revenue and credits | ✕ | ✕ | 7 | 9 | |||||
| Deferred tax liabilities | ✕ | (1) | |||||||
| Other undisclosed current liabilities | (5) | (2) | |||||||
| Total current liabilities: | 8 | 8 | 16 | 23 | 34 | 31 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 8 | 27 | |||||||
| Long-term debt, excluding current maturities | 8 | 27 | |||||||
| Liabilities, other than long-term debt, including: | 4 | 4 | 4 | 6 | 35 | 6 | |||
| Deferred revenue and credits | ✕ | ✕ | 0 | 0 | 1 | ||||
| Deferred tax liabilities, net | ✕ | 3 | |||||||
| Liability for uncertainty in income taxes | 4 | 4 | 4 | 3 | 3 | 3 | |||
| Regulatory liability | 0 | 3 | 3 | ||||||
| Restructuring reserve | 0 | 1 | |||||||
| Disposal group, including discontinued operation, liabilities | 0 | 1 | |||||||
| Other liabilities | 0 | 0 | 0 | 0 | 0 | ||||
| Business combination, contingent consideration, liability | 26 | ✕ | |||||||
| Other undisclosed liabilities, other than long-term debt | 0 | ||||||||
| Other undisclosed noncurrent liabilities | 0 | 1 | 7 | (53) | (1) | ||||
| Total noncurrent liabilities: | 4 | 6 | 19 | 6 | 9 | 5 | |||
| Other undisclosed liabilities | 3 | 25 | 53 | ||||||
| Total liabilities: | 16 | 14 | 35 | 55 | 96 | 37 | |||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | 33 | 40 | 7 | 13 | 20 | 32 | |||
| Common stock | 0 | 0 | 0 | ||||||
| Treasury stock, value | (2) | (2) | (2) | (8) | (14) | (14) | |||
| Additional paid in capital | 176 | 173 | 128 | 133 | 134 | 130 | |||
| Accumulated other comprehensive income | 0 | 0 | 0 | ||||||
| Accumulated deficit | (141) | (132) | (120) | (111) | (100) | (84) | |||
| Other undisclosed stockholders' equity attributable to parent | 0 | 0 | 0 | ||||||
| Total stockholders' equity: | 33 | 40 | 7 | 13 | 20 | 32 | |||
| TOTAL LIABILITIES AND EQUITY: | 48 | 54 | 42 | 68 | 116 | 69 | |||
Income statement (P&L) ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 22 | 16 | 13 | 9 | 120 | 151 | ||
| Revenue, net | ✕ | ✕ | 16 | 13 | 9 | 120 | 151 | |
| Cost of revenue | (10) | (7) | (7) | (7) | (129) | (157) | ||
| Cost of goods and services sold | (10) | (129) | (157) | |||||
| Other undisclosed gross profit | 27 | 31 | ||||||
| Gross profit: | 12 | 9 | 6 | 3 | 19 | 24 | ||
| Operating expenses | (24) | (15) | (13) | (43) | (32) | (29) | ||
| Operating loss: | (12) | (6) | (6) | (40) | (13) | (4) | ||
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | 0 | (2) | 0 | (0) | (0) | (0) | ||
| Interest and debt expense | (0) | (5) | (2) | (0) | (1) | |||
| Loss from continuing operations before equity method investments, income taxes: | (12) | (13) | (9) | (41) | (14) | (4) | ||
| Other undisclosed loss from continuing operations before income taxes | (3) | |||||||
| Loss from continuing operations before income taxes: | (12) | (13) | (9) | (44) | (14) | (4) | ||
| Income tax expense (benefit) | (0) | 0 | 0 | 13 | 5 | (0) | ||
| Loss from continuing operations: | (12) | (13) | (8) | (31) | (9) | (5) | ||
| Income (loss) from discontinued operations | 0 | 1 | 0 | 20 | (7) | (0) | ||
| Net loss available to common stockholders, diluted: | (12) | (12) | (8) | (11) | (16) | (5) | ||
Comprehensive Income ($ in millions)
| 9/30/2019 TTM | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (12) | (12) | (8) | (11) | (16) | (5) | ||
| Comprehensive loss: | (12) | (12) | (8) | (11) | (16) | (5) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (0) | 0 | ||||||
| Comprehensive loss, net of tax, attributable to parent: | (12) | (12) | (8) | (11) | (16) | (5) | ||
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.